The Updated COVID-19 Vaccine: Decoding the Shift to XBB
Thursday, September 21st at 7:30 AM EST/2:30 PM IDT
Learning objectives are:
Interested in learning more about the updated vaccine? Register for our webinar in the fall on this topic.
Fusce et arcu maximus, faucibus erat non, accumsan odio. Donec vitae semper ante, sit amet feugiat risus.
Quisque eu nibh in tortor euismod mattis id id leo. Proin malesuada vehicula nulla, id rutrum dolor fringilla in.
Quisque eu nibh in tortor euismod mattis id id leo. Proin malesuada vehicula nulla, id rutrum dolor fringilla in.
Maecenas gravida mauris quis consectetur tempor. Aenean at volutpat enim. Pellentesque eu lacus vulputate, semper arcu nec, dictum felis. luctus ligula vitae ex aliquam pulvinar. Pellentesque non hendrerit sem. Curabitur placerat, ex ut pharetra ultrices, mper turpis.
Maecenas gravida mauris quis consectetur tempor. Aenean at volutpat enim. Pellentesque eu lacus vulputate, semper arcu nec, dictum felis. luctus ligula vitae ex aliquam pulvinar. Pellentesque non hendrerit sem. Curabitur placerat, ex ut pharetra ultrices, mper turpis.
Maecenas gravida mauris quis consectetur tempor. Aenean at volutpat enim. Pellentesque eu lacus vulputate, semper arcu nec, dictum felis. luctus ligula vitae ex aliquam pulvinar. Pellentesque non hendrerit sem. Curabitur placerat, ex ut pharetra ultrices, mper turpis.
Prof David Strain is an Associate Professor of Cardiometabolic Health at the University of Exeter Medical School, an honorary consultant in medicine for the older adult, Head of the academic department for healthcare for older adults and the chair of the British Medical Association’s Board of Science. Clinically, he runs a community diabetes service for the older adult, works as an in-patient stroke consultant, and participates in the chronic fatigue service. Prior to this, Dr Strain studied at Liverpool University before completing his Doctorate in Medicine on ‘Ethnic differences in the vascular responses to insulin resistance’ at the International Centre for Cardiovascular Health, Imperial College, London.
Gili Regev-Yochay, is a full Professor at the Tel-Aviv University, Faculty of Medicine. She is currently the Director of the Sheba Pandemic preparedness Research Institute (SPRI) and the Head of the Infection Prevention & Control Unit at the Sheba Medical Center, Tel Hashomer, Israel. She received her MD at Ben Gurion University, Beer-Sheva (1994), an MSc in Neurobiology at the Weizmann Institute, Rehovot (1991), and MSc in Infectious Disease Epidemiology at the Harvard School of Public Health, Boston, MA. USA (2006). She has specialized in Internal Medicine (1998) and Infectious Diseases (2000) at the Sheba Medical Center. She is the author of over 130 scientific publications, among them many in the top medical and scientific journals. During the COVID-19 pandemic she was a local, national and global opinion leader in the field.
Thushan de Silva is an academic infectious disease physician with research interests in clinical discovery science focused on respiratory viral infections, viral immunology and vaccines. His research spans projects in the UK and Africa, with a portfolio that involves applied genomics and immunology in three inter-related areas: (i) Antiviral immune responses in the context of vaccination and natural infection, including in immunosuppressed individuals (ii) the molecular epidemiology and diagnosis of SARS-CoV-2 and other respiratory viruses and (iii) The molecular epidemiology, transmission and immunity to Streptococcus pyogenes. He has published >150 peer reviewed publications and secured >£6.5M in research income as a principal investigator and is a co-investigator in networks that have secured >£15M.
Maecenas gravida mauris quis consectetur tempor. Aenean at volutpat enim. Pellentesque eu lacus vulputate, semper arcu nec, dictum felis. luctus ligula vitae ex aliquam pulvinar. Pellentesque non hendrerit sem. Curabitur placerat, ex ut pharetra ultrices, mper turpis.